Show simple item record

dc.contributor.authorWalsh, T N
dc.contributor.authorNoonan, N
dc.contributor.authorHollywood, D
dc.contributor.authorKelly, A
dc.contributor.authorKeeling, N
dc.contributor.authorHennessy, T P
dc.date.accessioned2017-06-09T10:47:18Z
dc.date.available2017-06-09T10:47:18Z
dc.date.issued1996-08-15
dc.identifier.citationA comparison of multimodal therapy and surgery for esophageal adenocarcinoma. 1996, 335 (7):462-7 N. Engl. J. Med.en
dc.identifier.issn0028-4793
dc.identifier.pmid8672151
dc.identifier.doi10.1056/NEJM199608153350702
dc.identifier.urihttp://hdl.handle.net/10147/621423
dc.description.abstractUncontrolled studies suggest that a combination of chemotherapy and radiotherapy improves the survival of patients with esophageal adenocarcinoma. We conducted a prospective, randomized trial comparing surgery alone with combined chemotherapy, radiotherapy, and surgery.
dc.language.isoenen
dc.rightsArchived with thanks to The New England journal of medicineen
dc.subjectCANCER, OESOPAHGEALen
dc.subjectSURGERYen
dc.subjectRADIOTHERAPYen
dc.subjectCHEMOTHERAPYen
dc.subject.meshAdenocarcinoma
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshCisplatin
dc.subject.meshCombined Modality Therapy
dc.subject.meshEsophageal Neoplasms
dc.subject.meshFemale
dc.subject.meshFluorouracil
dc.subject.meshHospital Mortality
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Staging
dc.subject.meshProspective Studies
dc.subject.meshSurvival Analysis
dc.subject.meshTreatment Outcome
dc.subject.otherAdenocarcinoma/therapyen
dc.titleA comparison of multimodal therapy and surgery for esophageal adenocarcinoma.en
dc.typeArticleen
dc.identifier.journalThe New England journal of medicineen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-27T21:55:00Z
html.description.abstractUncontrolled studies suggest that a combination of chemotherapy and radiotherapy improves the survival of patients with esophageal adenocarcinoma. We conducted a prospective, randomized trial comparing surgery alone with combined chemotherapy, radiotherapy, and surgery.


Files in this item

Thumbnail
Name:
A comparison of multimodal therapy ...
Size:
80.44Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record